Compounding Packaging Webinar 
epicur
AUGUST 8, 2023
Implementation of GFI #256 Earlier this year, the FDA finalized regulatory guidance for compounded medications, known as GFI #256. If GFI is affecting your practice’s ability to get compounded medications for office use, partnering with a trusted 503B outsourcing facility can help you eliminate risks of limited ordering.
Quality Matters
NOVEMBER 11, 2022
Nitrosamines’ emergence in drug products Nitrosamines are organic chemical compounds that may be present in low levels in a wide variety of products such as processed meats, cosmetics and cigarette smoke. When they are metabolized, they are converted to alkylating agents that can damage DNA and have been linked to cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Viseven
AUGUST 15, 2024
Engagement can lead to improvements in drug delivery methods, packaging designs, and support services that enhance the overall patient experience. This education can be delivered through various formats, such as webinars, videos, and written materials.
Pharmaceutical Technology
FEBRUARY 23, 2023
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.
Pharmaceutical Technology
MARCH 22, 2023
According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.
Expert insights. Personalized for you.
52 
Let's personalize your content